These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38462132)

  • 1. Reply to: "Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies".
    Ghany MG; Buti M; Lampertico P; Lee HM
    J Hepatol; 2024 Jul; 81(1):e26-e27. PubMed ID: 38462132
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies.
    Anderson M; Holzmayer V; Stec M; Cloherty G; Lim SG
    J Hepatol; 2024 Jul; 81(1):e24-e25. PubMed ID: 38036010
    [No Abstract]   [Full Text] [Related]  

  • 3. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which Is More Clinically Relevant: End-of-Treatment or Off-Treatment Predictors of Hepatitis B Relapse and Surface Antigen Loss?
    Zheng D; Fang Z; Sun J
    Gastroenterology; 2024 Jun; 166(6):1193-1194. PubMed ID: 37890561
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of Clinical Relapse and HBsAg Loss After Cessation of Anti-HBV Therapy.
    Liaw YF
    Gastroenterology; 2024 Jun; 166(6):1193. PubMed ID: 37866763
    [No Abstract]   [Full Text] [Related]  

  • 6. HBsAg Kinetics in Retreatment Decision for Off-Therapy Hepatitis B Flare in HBeAg-Negative Patients.
    Liaw YF; Jeng WJ; Chang ML
    Gastroenterology; 2018 Jun; 154(8):2280-2281. PubMed ID: 29746811
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients.
    Chan HL; Wong GL; Chim AM; Chan HY; Chu SH; Wong VW
    Antivir Ther; 2011; 16(8):1249-57. PubMed ID: 22155906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
    Janssen HL; Sonneveld MJ; Brunetto MR
    Gut; 2012 May; 61(5):641-5. PubMed ID: 22180061
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantification of hepatitis B virus HBsAg: clinical implications].
    Buti M; Rodríguez Frías F; Esteban R
    Med Clin (Barc); 2012 Apr; 138(11):483-8. PubMed ID: 21719049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
    Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
    J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response.
    Sonneveld MJ; Zoutendijk R; Flink HJ; Zwang L; Hansen BE; Janssen HL
    Clin Infect Dis; 2013 Jan; 56(1):100-5. PubMed ID: 23042976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
    Schubert A; Michel D; Mertens T
    BMC Infect Dis; 2013 May; 13():223. PubMed ID: 23679074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
    Le Bert N; Gill US; Hong M; Kunasegaran K; Tan DZM; Ahmad R; Cheng Y; Dutertre CA; Heinecke A; Rivino L; Tan A; Hansi NK; Zhang M; Xi S; Chong Y; Pflanz S; Newell EW; Kennedy PTF; Bertoletti A
    Gastroenterology; 2020 Aug; 159(2):652-664. PubMed ID: 32302614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early serum hepatitis B virus large surface protein level: a stronger predictor of virological response to peginterferon alfa-2a than that to entecavir in HBeAg-positive patients with chronic hepatitis B.
    Zhu X; Gong Q; Yu D; Zhang D; Gu L; Han Y; Chen J; Zhang Y; Zhang X
    J Clin Virol; 2013 Aug; 57(4):318-22. PubMed ID: 23639294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ordering and interpreting hepatitis B serology.
    Davison SA; Strasser SI
    BMJ; 2014 Apr; 348():g2522. PubMed ID: 24742733
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.
    Wong RJ; Nguyen MT; Trinh HN; Chan C; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Torres S; Yang J; Liu B; Garcia RT; Bhuket T; Baden R; Levitt B; da Silveira E; Gish RG
    J Viral Hepat; 2017 Dec; 24(12):1089-1097. PubMed ID: 28581644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy.
    Wang Z; Li X; Shi C; Zhang M; Chen R; Wu W; Hou Q; Ke W; Fan T; Wen Z; Hao X; Qu N
    Mol Med Rep; 2015 Jan; 11(1):427-33. PubMed ID: 25324041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New viral biomarkers for Hepatitis B: Are we able to change practice?
    Höner Zu Siederdissen C; Maasoumy B; Cornberg M
    J Viral Hepat; 2018 Nov; 25(11):1226-1235. PubMed ID: 30187603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
    Idilman R; Cinar K; Seven G; Bozkus Y; Elhan A; Bozdayi M; Yurdaydin C; Bahar K
    J Viral Hepat; 2012 Mar; 19(3):220-6. PubMed ID: 22329377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory diagnosis of hepatitis B].
    Forns X; Sánchez-Tapias JM
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():7-14. PubMed ID: 11279897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.